USADA announced today that Oskar Piechota, of Pomorskie, Poland, has accepted a 22-month sanction for a violation of the UFC^® Anti-Doping Policy. Piechota, 31, tested positive for growth hormone releasing peptide 2 (GHRP-2 or pralmorelin) and GHRP-2 (1-3) free acid, a metabolite of GHRP-2, as the result of a urine sample collected on September 25, 2020.

GHRP-2 is a Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List. Piechota received a reduction to the default two-year sanction based on his Full and Complete Cooperation. His 22-month period of ineligibility began on September 25, 2020, the date his positive sample was collected.

• This media release was published by the Ultimate Fighting Championships (UFC) and the US Anti-Doping Agency (USADA) on 5 May 2021. Click here for the original.